News
MCRPF
1.570
NaN%
--
J.P. Morgan Keeps Their Buy Rating on MicroPort Scientific (MCRPF)
TipRanks · 6d ago
MicroPort Sets Up Global Executive Committee and Reshapes Top Management Roles
TipRanks · 03/31 20:59
MicroPort Returns to Profitability as Platform Strategy and Cardiac Portfolio Drive New Growth
TipRanks · 03/31 20:51
MicroPort Scientific Appoints New Company Secretary and Authorised Representative
TipRanks · 03/31 20:49
MicroPort Unit Endovastec Posts Double‑Digit Revenue and Earnings Growth in 2025
TipRanks · 03/30 17:29
MicroPort Sets March 31 Board Meeting to Approve 2025 Final Results
TipRanks · 03/19 09:14
MicroPort Unit Endovastec Posts Double-Digit Revenue and Earnings Growth in 2025
TipRanks · 02/27 12:44
MicroPort Scientific Flags Return to Profit on Overseas Growth and Cost Cuts
TipRanks · 01/22 15:07
MicroPort Deconsolidates Neuro Device Subsidiary After Loss of Board Control
TipRanks · 12/30/2025 15:12
MicroPort Scientific Announces Strategic Merger to Enhance Competitiveness in Cardiovascular Devices
TipRanks · 12/15/2025 15:10
Bank of America Securities Keeps Their Buy Rating on MicroPort Scientific (MCRPF)
TipRanks · 11/15/2025 00:29
MicroPort Scientific Reports Mixed Financial Results for Endovastec
TipRanks · 10/29/2025 12:07
MicroPort Scientific Adopts New Governance Framework
TipRanks · 10/22/2025 12:13
MicroPort Scientific (MCRPF) Receives a Hold from Nomura
TipRanks · 10/01/2025 06:36
MicroPort Scientific Announces Board Restructuring
TipRanks · 09/30/2025 14:12
MicroPort Scientific Announces Board Composition and Committee Roles
TipRanks · 09/30/2025 14:11
MicroPort Scientific Announces EGM to Revise Governance Documents
TipRanks · 09/30/2025 14:09
MicroPort Scientific Announces Strategic Merger to Enhance Cardiac Solutions
TipRanks · 09/29/2025 15:09
Weekly Report: what happened at MCRPF last week (0908-0912)?
Weekly Report · 09/15/2025 10:02
Weekly Report: what happened at MCRPF last week (0901-0905)?
Weekly Report · 09/08/2025 10:04
More
Webull provides a variety of real-time MCRPF stock news. You can receive the latest news about Microport Scien through multiple platforms. This information may help you make smarter investment decisions.
About MCRPF
Microport Scientific Corp Microport Scientific Corp is an investment holding company mainly engaged in the sale, manufacture, research and development (R&D) of medical devices. The Company operates in eight segments. The Cardiovascular Devices Business segment includes implantable devices and access devices. The Orthopedics Devices Business segment includes reconstructive joints and spine products. The Cardiac Rhythm Management (CRM) Business segment includes pacemakers and defibrillators. The Endovascular and Peripheral Vascular Devices Business segment includes L-REBOA aortic occlusion balloons. The Neurovascular Devices Business segment includes cerebral atherosclerotic stenosis and coil products. The Structural Heart Disease Business segment includes Transcatheter Aortic Valve Implantation. The Surgical Robot Business segment includes the manufacture and R&D of surgical robot devices. The Surgical Devices Business segment includes the manufacture and R&D of surgical devices.